G-CSF treatment for tumor patients with chemotherapy-associated neutropenia raises more questions as well, as new evidence suggests that G-CSF might exacerbate the immune suppression environment in tumors (Mouchemore and Anderson, 2021). This evidence concerns the gene CSF3 and Decreased total neutrophil count.